Conmed (CNMD) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
CONMED (CNMD) PT Raised to $58 at Needham & Company Following 3Q Report
November 3, 2017 8:29 AM EDTNeedham & Company raised its price target on CONMED (NASDAQ: CNMD) to $58.00 (from $57.00) while maintaining a Buy rating following the company's 3Q release. Revenue was $190.1M vs. consensus of $187.1M and EPS was $0.42 vs. consensus of $0.41. lower than expected tax rate added ~$0.03 to... More
